Immune

LL-37

Cathelicidin / hCAP18 fragment

Peptide length
37 amino acids

Cationic antimicrobial peptide

Research contextHuman studies exist

Read the linked studies for their methods and limitations.

A human host-defense peptide with antimicrobial laboratory research and small formulation-specific wound trials.

Family
Host-defense peptide
Research frame
Membrane and immune signaling
Molecular format
Cationic antimicrobial peptide

Read the evidence

The cited venous-ulcer trial studied topical treatment in 34 participants, with outcomes differing across dose groups. It does not establish systemic antimicrobial therapy.

Resolve the identity

Distinguish the mature LL-37 peptide from hCAP18 precursor, fragments and formulated products.